Idiopathic Hypersomnia Medical Education Grant
Jazz Pharmaceuticals (Jazz) is committed to improving patient outcomes and providing support in compliance with local regulations.
Idiopathic Hypersomnia (US and Canada Only)
- Screening, differential diagnosis, and management of Idiopathic Hypersomnia
- Burden of symptoms associated with Idiopathic Hypersomnia (eg, sleep inertia, EDS, prolonged sleep duration) and the impact of treatment, including efficacy, safety, and quality of life considerations,
- The clinical comorbidity burden of Idiopathic Hypersomnia, including cardiovascular/cardiometabolic comorbidities, and impact of treatment choices
- The potential impact of excessive sodium intake on health and relevance of this risk in Idiopathic Hypersomnia patients
Jazz Pharmaceuticals (JAZZ) is committed to advancing scientific knowledge and clinical expertise within the medical and scientific communities with the ultimate goal of improving patient care.
This site allows you to submit Independent Medical Education (IME) requests for US and Ex-US activities or initiatives that serve to maintain, develop, or increase the knowledge, skills, and/or professional performance of healthcare professionals (e.g., continuing medical education, continuing health education, continuing education).
IME is supported education (accredited or non-accredited) in which JAZZ exercises no control, influence, or direction over any aspect of the program, including but not limited to educational design, faculty, authors, speakers, etc. All grants must comply with local regulations.
We are currently accepting requests for:
- Meetings, Conferences, or Symposia
- Medical Center Grand Rounds lectures
- Fellowships
- Enduring IME activities, which may include strategies, tools, and other educational resources to use with patients
- Patient education in conjunction with Health Care Provider (HCP) education
PIRA™ proposals are AI generated and are not reviewed or endorsed by the sponsoring company.